Quantitative Choroid Plexus Gadolinium Enhancement Is Related to Diffuse Brain Tissue Injury in Multiple Sclerosis
Journal of Neuroimaging · 2026-03 · 36 (2)
DOI: 10.1111/jon.70132 ↗At a glance
Journal article in Journal of Neuroimaging, published online on 2026-03-09. Written by Sneha Senthil and 10 co-authors. Institution: McConnell Brain Imaging Centre, Montreal Neurological Institute-Hospital, McGill University, Montreal, Quebec, Canada. Major MEDLINE topics: Choroid Plexus, Magnetic Resonance Imaging, Multiple Sclerosis, Brain Injuries. Cited 1 times so far (Crossref); 44 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: CIHR, U.S. Department of Defense, from Novartis Canada.
Abstract (original language)
Background
Recent studies suggest that disruptions of the blood–cerebrospinal fluid (CSF) barrier within the choroid plexus (ChP) may contribute to multiple sclerosis (MS) pathogenesis. We investigated the relationship between a quantitative marker of ChP enhancement and markers of focal and diffuse brain tissue injury in MS.
Methods
A group of 34 MS participants and 21 healthy participants underwent 7T MRI including magnetization prepared 2 rapid acquisition gradient echoes (MP2RAGE) and fluid attenuated inversion recovery (FLAIR) acquisitions. The MS group received contrast, and delta T1 (ΔT1) maps were computed to assess enhancement. ChP, white matter lesions (WML), normal‐appearing white matter (NAWM), and gray matter (GM) were segmented. Pre‐contrast quantitative T1 (qT1) values were compared between groups, and linear regression with mean ChP ΔT1 was performed for WML volume and pre‐gadolinium (Gd) mean qT1 of WML, NAWM, and GM.
Results
Mean qT1 of ChP, NAWM, and GM, as well as ChP volume, were higher in MS compared to controls ( p < 0.001). ChP ΔT1 was significantly associated with pre‐Gd qT1 of NAWM ( β = 0.20, R 2 = 0.54, p < 0.001) and GM ( β = 0.18, R 2 = 0.49, p < 0.001), but not WML volume ( p = 0.3) or WML qT1 ( p = 0.05).
Conclusions
The association between ChP enhancement and diffuse tissue injury, together with elevated qT1 values and ChP volumes in MS, supports a mechanism of brain injury involving CSF‐mediated toxicity distinct from classic lesion pathology in MS.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- McConnell Brain Imaging Centre, Montreal Neurological Institute-Hospital, McGill University, Montreal, Quebec, Canada.
- Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.
- NeuroRx Research, Montreal, Quebec, Canada.
- Department of Pathology and Laboratory Medicine, International Collaboration on Repair Discoveries (ICORD), University of British Columbia, Vancouver, British Columbia, Canada.
- Department of Biomedical Engineering, McGill University, Montreal, Quebec, Canada.
ORCID profiles: Sneha Senthil
Funding
- CIHR
- U.S. Department of Defense
- from Novartis Canada
- Canadian Institutes of Health Research
Cite
APA
Senthil, S., Tagge, I., Fetco, D., Hsieh, C. H., Assemlal, H. E., Karimaghaloo, Z., Fetco, E., Moore, G. R. W., Arnold, D. L., Rudko, D. A., & Narayanan, S. (2026). Quantitative Choroid Plexus Gadolinium Enhancement Is Related to Diffuse Brain Tissue Injury in Multiple Sclerosis. Journal of Neuroimaging, 36(2). https://doi.org/10.1111/jon.70132
Vancouver
Senthil S, Tagge I, Fetco D, Hsieh CH, Assemlal HE, Karimaghaloo Z, et al. Quantitative Choroid Plexus Gadolinium Enhancement Is Related to Diffuse Brain Tissue Injury in Multiple Sclerosis. Journal of Neuroimaging. 2026;36(2). doi:10.1111/jon.70132
BibTeX
@article{Senthil2026,
author = {Senthil, Sneha and Tagge, Ian and Fetco, Dumitru and Hsieh, Cheng Hsun and Assemlal, Haz-Edine and Karimaghaloo, Zahra and Fetco, Emily and Moore, G R Wayne and Arnold, Douglas L and Rudko, David A and Narayanan, Sridar},
title = {Quantitative Choroid Plexus Gadolinium Enhancement Is Related to Diffuse Brain Tissue Injury in Multiple Sclerosis},
journal = {Journal of Neuroimaging},
year = {2026},
volume = {36},
number = {2},
doi = {10.1111/jon.70132}
}
EUVIMED